John Varley, the former chief executive of Barclays, will be thrust back into the City spotlight as investors seek assurances that AstraZeneca will link boardroom pay to targets used to rebuff a recent £69bn takeover bid.
Sky News understands that a number of big AstraZeneca shareholders have requested meetings with Mr Varley, who chairs the pharmaceuticals group's remuneration committee, to discuss a revised set of criteria for executives' long-term share awards.
Help employers find you! Check out all the jobs and post your resume.